CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients.

MLA

Luo, Mengqi, et al. “CXCR7 Genetic Variant Predicts Treatment Response of Pegylated-Interferon α in HBeAg-Positive Chronic Hepatitis B Patients.” Antiviral Research, vol. 231, Nov. 2024, p. 106005. EBSCOhost, https://doi.org/10.1016/j.antiviral.2024.106005.

APA

Luo, M., Liang, X., Zhou, B., Hou, J., & Jiang, D.-K. (2024). CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients. Antiviral Research, 231, 106005. https://doi.org/10.1016/j.antiviral.2024.106005

Chicago

Luo, Mengqi, Xinghe Liang, Bin Zhou, Jinlin Hou, and De-Ke Jiang. 2024. “CXCR7 Genetic Variant Predicts Treatment Response of Pegylated-Interferon α in HBeAg-Positive Chronic Hepatitis B Patients.” Antiviral Research 231 (November): 106005. doi:10.1016/j.antiviral.2024.106005.